BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology


1/18/2012 9:07:52 AM

Tokyo, Japan, January 18, 2012/ B3C newswire / – JSR Corporation (Head Office: Minato-Ku, Tokyo, President: Mitsunobu Koshiba) and BIA Separations (Head Office: Villach, Managing Director and CEO: Aleš Štrancar) announced that they have entered a strategic partnership which includes a minor equity position by JSR on November 14th 2011. As a result of this investment, JSR and BIA Separations have started a joint global marketing and sales effort and collaborative R&D activities in the area of downstream purification as part of the manufacturing of vaccine, DNA and antibody based medicines.

From JSR’s perspective, teaming up with BIA Separations will give JSR access to a unique and leading edge technology in the field of downstream purification of large bio-molecules. Combining this technology with JSR’s proprietary Protein A media, we offer the bio pharmaceutical industry a faster, more reliable downstream purification process at a lower cost of ownership. This will contribute to making advanced treatments accessible to a larger part of the human society.

BIA Separations recognizes that JSR Corporation is a leading polymer chemistry manufacturer with a very strong commitment to the life sciences industry. JSR’s global presence in the local markets and JSR’s expertise in the field of consistent high quality volume manufacturing will help BIA Separations to successfully grow its business while maintaining its technological leadership. This partnership is a very important message to the industry as it secures the long term presence of BIA Separations and its technology and products on the market.

About JSR

JSR Corporation is a multinational company employing over 5000 people worldwide and a leading materials supplier in a variety of technology driven markets. JSR’s global network is headquartered in Tokyo ( Japan) and has factories and offices in Europe, US, China, Taiwan, Korea and Singapore. JSR is a research-oriented organization that pursues close collaborations with leading innovators in a number of industries that are a key to the present and future welfare of human society: life-sciences, energy storage, electronic materials, display and optical materials. For more information about JSR Corporation, please go to www.jsr.co.jp or call Yoshiko Takeda at +81 3 6218-3517.

About BIA Separations

BIA Separations is the only worldwide developer and manufacturer of CIM Convective Interaction Media® -- short monolithic chromatographic columns optimized for the separation and purification of large bio-molecules and viral particles on the laboratory and industrial scale. For more information about BIA Separations, please visit www.biaseparations.com or call Gregor Kranjc at +386 59 699 500.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->